HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].

Abstract
We retrospectively investigated the efficacy of high dose omeprazole compared to a combined therapy of famotidine, pirenzepine and antacid for acute upper gastrointestinal hemorrhage (AUGIH) also adjuvant to endoscopic injection therapy if indicated. The clinical course of AUGIH was evaluated, if emergency endoscopy revealed lesions substantially dependent on intragastric acidity with respect to pathogenesis and/or healing (peptic ulcer, erosive gastroduodenitis, reflux-esophagitis, Mallory-Weiss tears) and patients either received a combined therapy of famotidine (20 mg i.v. every 12 hrs), pirenzepine (10 mg i.v. every 12 hrs) and antacid (control group: n = 96) or omeprazole (40 mg i.v. every 6 hrs; omeprazole group: n = 100). Rate of rebleeding was lower in the omeprazole group without reaching significance (12 vs. 21; p = 0.06). No difference was found for rates of operation (6 vs. 6; p = 0.94), death from bleeding (5 vs. 9; p = 0.22), transfusions ([mean +/- SD] 3.3 +/- 5.0 vs. 3.2 +/- 5.7; p = 0.51) and hospitalisation ([mean +/- SD] 26.8 +/- 12.1 vs. 27.8 +/- 16.0 days; p = 0.88). Considering prognostic risk factors (age > or = 65, actively bleeding lesion, initial state of shock) logistic regression showed that high dose omeprazole inhibited rebleeding (p = 0.01) but had no effect as regards surgery or mortality. Within two selected subgroups defined by additional criteria (no endoscopic treatment and anamnestic peptic lesion) omeprazole-treated cases showed lower rates of rebleeding (3/49 vs. 12/54, p " 0.02 and 3/44 vs. 13/48, p = 0.01 resp.) and death from bleeding (0/46 vs. 6/50, p = 0.03 and 0/43 vs. 5/45, p = 0.03 resp.).(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsJ Busam, W E Garbe
JournalZeitschrift fur Gastroenterologie (Z Gastroenterol) Vol. 32 Issue 2 Pg. 94-9 (Feb 1994) ISSN: 0044-2771 [Print] Germany
Vernacular TitleOmeprazol hochdosiert versus Famotidin, Pirenzepin und Antazidum in der Therapie der akuten oberen gastrointestinalen Blutung im retrospektiven Vergleich.
PMID8165833 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antacids
  • Pirenzepine
  • Aluminum Hydroxide
  • Famotidine
  • magaldrate
  • Omeprazole
  • Magnesium Hydroxide
Topics
  • Aged
  • Aged, 80 and over
  • Aluminum Hydroxide (administration & dosage, adverse effects)
  • Antacids (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Endoscopy, Digestive System
  • Famotidine (administration & dosage, adverse effects)
  • Gastrointestinal Hemorrhage (drug therapy, etiology, mortality)
  • Humans
  • Magnesium Hydroxide (administration & dosage, adverse effects)
  • Omeprazole (administration & dosage, adverse effects)
  • Peptic Ulcer Hemorrhage (drug therapy, etiology, mortality)
  • Pirenzepine (administration & dosage, adverse effects)
  • Recurrence
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: